Versatile effects of sildenafil: recent pharmacological applications.
暂无分享,去创建一个
Vishnu Suppiramaniam | Subramaniam Uthayathas | Senthilkumar S Karuppagounder | Bessy M Thrash | Kodeeswaran Parameshwaran | Muralikrishnan Dhanasekaran | V. Suppiramaniam | Senthilkumar S. Karuppagounder | M. Dhanasekaran | Subramaniam Uthayathas | Kodeeswaran Parameshwaran | Bessy Thrash
[1] A. Blokland,et al. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information , 2004, Neurochemistry International.
[2] Sophie Pezet,et al. Neurotrophins: mediators and modulators of pain. , 2006, Annual review of neuroscience.
[3] A. Rashid. The efficacy and safety of PDE5 inhibitors. , 2005, Clinical cornerstone.
[4] F. Montorsi,et al. A 4-year update on the safety of sildenafil citrate (Viagra). , 2002, Urology.
[5] F. Montorsi,et al. Emerging oral drugs for erectile dysfunction , 2004, Expert opinion on emerging drugs.
[6] C. S. Patil,et al. Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. , 2006, Pharmacological reports : PR.
[7] R. Barker,et al. Neurogenesis in diseases of the central nervous system. , 2006, Stem cells and development.
[8] R. Schreiber,et al. Improving memory: a role for phosphodiesterases. , 2006, Current pharmaceutical design.
[9] M. Chopp,et al. Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia , 2006, Journal of neuroscience research.
[10] Herbert Weingartner,et al. NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.
[11] E. Klings,et al. Present and future treatment strategies for pulmonary arterial hypertension : focus on phosphodiesterase-5 inhibitors. , 2006, Treatments in respiratory medicine.
[12] M. Fujita,et al. Kinetics of glutamate and gamma-aminobutyric acid in cerebrospinal fluid in a canine model of complex partial status epilepticus induced by kainic acid. , 2004, The Journal of veterinary medical science.
[13] I. Øye,et al. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain , 1995, Pain.
[14] J. Altman,et al. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.
[15] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[16] John Garthwaite,et al. On the Role of Nitric Oxide in Hippocampal Long-Term Potentiation , 2003, The Journal of Neuroscience.
[17] G. Wegener,et al. Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. , 2003, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[18] Y. Ge. Multiple sclerosis: the role of MR imaging. , 2006, AJNR. American journal of neuroradiology.
[19] Y. Lampl,et al. Tonic-clonic seizures in patients taking sildenafil , 2002, BMJ : British Medical Journal.
[20] R. Nicoll,et al. Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus. , 1996, Learning & memory.
[21] B. Beltz,et al. From Embryo to Adult: Persistent Neurogenesis and Apoptotic Cell Death Shape the Lobster Deutocerebrum , 1999, The Journal of Neuroscience.
[22] F. Gage,et al. Adult neurogenesis and neural stem cells of the central nervous system in mammals , 2002, Journal of neuroscience research.
[23] R. Shamloul. CASE REPORT: Management of Honeymoon Impotence , 2006 .
[24] L. Caplan,et al. Transient global amnesia after sildenafil (Viagra) use. , 2002, Neurology.
[25] H. Milman,et al. Neurologic, Psychological, and Aggressive Disturbances with Sildenafil , 2002, The Annals of pharmacotherapy.
[26] S. Hayreh. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship? , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[27] L. Gorkin,et al. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy , 2006, International journal of clinical practice.
[28] R. Sandeman,et al. "Impoverished" and "enriched" living conditions influence the proliferation and survival of neurons in crayfish brain. , 2000, Journal of neurobiology.
[29] A. Laties,et al. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. , 2006, The journal of sexual medicine.
[30] J. E. Torres-López,et al. Sildenafil increases diclofenac antinociception in the formalin test. , 2001, European journal of pharmacology.
[31] P. Pratt,et al. Differential Hemodynamic Responses to Selective Inhibitors of Cyclic Nucleotide Phosphodiesterases in Conscious Rats , 1992, Journal of cardiovascular pharmacology.
[32] Nirmal Singh,et al. Sildenafil improves acquisition and retention of memory in mice. , 2003, Indian journal of physiology and pharmacology.
[33] K. Galluzzi,et al. Management of Neuropathic Pain , 2005 .
[34] E. A. Schwartz,et al. A cGMP-gated current can control exocytosis at cone synapses , 1994, Neuron.
[35] C. S. Patil,et al. Sildenafil, a Phosphodiesterase-5 Inhibitor, Enhances the Antinociceptive Effect of Morphine , 2003, Pharmacology.
[36] J. Bremner. The Relationship Between Cognitive and Brain Changes in Posttraumatic Stress Disorder , 2006, Annals of the New York Academy of Sciences.
[37] B. Galer,et al. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. , 2000, Diabetes research and clinical practice.
[38] Aytaç,et al. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences , 1999, BJU international.
[39] R. Hawkins,et al. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. , 1998, Progress in brain research.
[40] C. Lois,et al. Long-distance neuronal migration in the adult mammalian brain. , 1994, Science.
[41] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[42] J. Corbin,et al. Mechanisms of action of PDE5 inhibition in erectile dysfunction , 2004, International Journal of Impotence Research.
[43] V. Granados-Soto,et al. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. , 2005, European journal of pharmacology.
[44] M. Guazzi,et al. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure , 2004, Clinical pharmacology and therapeutics.
[45] B. Manyam,et al. Botanical therapies in sexual dysfunction , 2005, Phytotherapy Research.
[46] C. Gross,et al. Neurogenesis in the neocortex of adult primates. , 1999, Science.
[47] O. Kukula,et al. Effect of sildenafil on anxiety in the plus-maze test in mice. , 2004, Polish journal of pharmacology.
[48] P. Eide,et al. Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia , 1995, Pain.
[49] Hugo Geerts,et al. Pharmacology of Acetylcholinesterase Inhibitors and N‐methyl‐d‐aspartate Receptors for Combination Therapy in the Treatment of Alzheimer's Disease , 2006, Journal of clinical pharmacology.
[50] S. Katz,et al. Sympathetic activation by sildenafil. , 2001, Circulation.
[51] I. Osterloh,et al. Past, present, and future: a 7‐year update of Viagra® (sildenafil citrate) , 2005, International journal of clinical practice.
[52] R. Dundore,et al. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. , 1993, European journal of pharmacology.
[53] D. Ingram,et al. Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement , 2005 .
[54] D. Fishbain,et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. , 2006, Mayo Clinic proceedings.
[55] E. Troisi,et al. Aging and stroke rehabilitation. a case-comparison study. , 2003, Cerebrovascular diseases.
[56] M. Chopp,et al. Functional Recovery in Aged and Young Rats After Embolic Stroke: Treatment With a Phosphodiesterase Type 5 Inhibitor , 2005, Stroke.
[57] D. van der Kooy,et al. Adult Mammalian Forebrain Ependymal and Subependymal Cells Demonstrate Proliferative Potential, but only Subependymal Cells Have Neural Stem Cell Characteristics , 1999, The Journal of Neuroscience.
[58] J. Garthwaite,et al. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase , 1995, Neuroscience.
[59] Z. Wiesenfeld‐Hallin. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? , 1998, Drugs.
[60] Richard H. Kramer,et al. Cyclic-nucleotide-gated channels mediate synaptic feedback by nitric oxide , 1997, Nature.
[61] J. Corbin,et al. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. , 1999, Molecular pharmacology.
[62] A. Blokland,et al. Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation , 2004, Psychopharmacology.
[63] R. Segraves,et al. ORIGINAL RESEARCH—WOMEN's SEXUAL DYSFUNCTIONSORIGINAL RESEARCH—WOMEN's SEXUAL DYSFUNCTIONS: The Sexual Interest and Desire Inventory—Female (SIDI‐F): Item Response Analyses of Data from Women Diagnosed with Hypoactive Sexual Desire Disorder , 2005 .
[64] G. Muirhead,et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.
[65] H. Bae,et al. Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test , 2005, Neuroscience Letters.
[66] F. Goto,et al. Somatotopy in Human Primary Somatosensory Cortex in Pain System , 2005, Anesthesiology.
[67] I. Izquierdo,et al. Further evidence for the involvement of a hippocampal cGMP/cGMP‐dependent protein kinase cascade in memory consolidation , 1997, Neuroreport.
[68] R. Kloner,et al. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. , 2003, Circulation.
[69] S. Kanba,et al. A decreased survival of proliferated cells in the hippocampus is associated with a decline in spatial memory in aged rats , 2006, Neuroscience Letters.
[70] H. Kehlet,et al. Peripheral Analgesic Effects of Ketamine in Acute Inflammatory Pain , 1998, Anesthesiology.
[71] A. Blokland,et al. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices , 2005, Behavioural Brain Research.
[72] Hendrik van den Bussche,et al. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials , 2005, BMJ : British Medical Journal.
[73] R. J. McDonald. Multiple combinations of co-factors produce variants of age-related cognitive decline: a theory. , 2002, Canadian journal of experimental psychology = Revue canadienne de psychologie experimentale.
[74] C. Gandolfo,et al. Sildenafil and transient global amnesia , 2003, Neurological Sciences.
[75] L. Ghiadoni,et al. Age-Related Reduction of NO Availability and Oxidative Stress in Humans , 2001, Hypertension.
[76] E. Troisi,et al. Aging and Stroke Rehabilitation , 2003, Cerebrovascular Diseases.
[77] Matthew S. Grubb,et al. Adult neurogenesis and functional plasticity in neuronal circuits , 2006, Nature Reviews Neuroscience.
[78] C. Svendsen,et al. Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex , 2006, The European journal of neuroscience.
[79] T. Jensen,et al. Management of neuropathic pain , 2007, Current opinion in supportive and palliative care.
[80] J. Olney,et al. Low Doses of Memantine Disrupt Memory in Adult Rats , 2006, The Journal of Neuroscience.
[81] C. S. Patil,et al. Modulatory Effect of the PDE-5 Inhibitor Sildenafil in Diabetic Neuropathy , 2004, Pharmacology.
[82] D. Bredt,et al. Regulation of Sensory Neuron Precursor Proliferation by Cyclic GMP‐Dependent Protein Kinase , 1998, Journal of neurochemistry.
[83] C. S. Patil,et al. Sildenafil-induced peripheral analgesia and activation of the nitric oxide–cyclic GMP pathway , 2001, Brain Research.
[84] E. Kandel,et al. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons , 1995, Nature.
[85] S. Stahl. Cholinesterase inhibitors for Alzheimer's disease. , 1998, Hospital practice.
[86] H. Ghofrani,et al. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.
[87] J. Morgan,et al. Transient ischemic attack and stroke associated with sildenafil (Viagra) use , 2001, Neurology.
[88] F. Pérez-Severiano,et al. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. , 2005, European journal of pharmacology.
[89] Omar Cauli,et al. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus Alterations in hyperammonemia , 2004, Neurochemistry International.
[90] P. Taupin. Neurogenesis in the adult central nervous system. , 2006, Comptes rendus biologies.
[91] D. Hatzichristou,et al. Psychological, Social, and Behavioural Benefits for Men Following Effective Erectile Dysfunction (ED) Treatment: Men Who Enjoy Better Sex Experience Improved Psychological Well-Being , 2006 .
[92] H. Homayoun,et al. The proconvulsant effect of sildenafil in mice: role of nitric oxide–cGMP pathway , 2006, British journal of pharmacology.
[93] H. Nurnberg. Introduction. Erectile dysfunction and comorbid depression: prevalence, treatment strategies, and associated medical conditions. , 2003, The Journal of clinical psychiatry.
[94] F. Graeff,et al. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. , 1997, European journal of pharmacology.
[95] S. Lewis. Aetiology of transient global amnesia , 1998, The Lancet.
[96] Manfred Schmidt,et al. Neuronal differentiation and long-term survival of newly generated cells in the olfactory midbrain of the adult spiny lobster, Panulirus argus. , 2001, Journal of neurobiology.
[97] P. Matthews,et al. Effect of sildenafil citrate on CBF and BOLD activation in multiple sclerosis patients , 2005 .
[98] F. Sommer,et al. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors , 2005, World Journal of Urology.
[99] Yingwang,et al. Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats , 2002 .
[100] V. Felipo,et al. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure Therapeutic implications , 2006, Neurochemistry International.
[101] G. Ronnett,et al. The localization of neuronal nitric oxide synthase may influence its role in neuronal precursor proliferation and synaptic maintenance. , 2004, Developmental biology.
[102] K. Heese,et al. Alzheimer's disease--an interactive perspective. , 2006, Current Alzheimer research.
[103] R. Segraves,et al. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. , 2005, The journal of sexual medicine.
[104] F. Nottebohm,et al. Birth of projection neurons in adult avian brain may be related to perceptual or motor learning. , 1990, Science.
[105] S. Read,et al. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. , 1997, Journal of public health medicine.
[106] A. Rilk,et al. Visual short-term effects of Viagra: double-blind study in healthy young subjects. , 2004, American journal of ophthalmology.
[107] M. Boccia,et al. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. , 1999, Behavioural pharmacology.
[108] H. Cameron,et al. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus , 1994, Neuroscience.
[109] C. Strambi,et al. Neurogenesis in adult insect mushroom bodies , 1996, The Journal of comparative neurology.
[110] R. Nelson,et al. Aggressive behavior increases after termination of chronic sildenafil treatment in mice , 2005, Physiology & Behavior.
[111] D. Ingram,et al. Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats , 2004, Pharmacology Biochemistry and Behavior.
[112] K. Nave,et al. Hippocampal cGMP-Dependent Protein Kinase I Supports an Age- and Protein Synthesis-Dependent Component of Long-Term Potentiation But Is Not Essential for Spatial Reference and Contextual Memory , 2003, The Journal of Neuroscience.
[113] A. Blokland,et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat , 2002, Neuroscience.
[114] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[115] F. Gage,et al. Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.
[116] V. Felipo,et al. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts , 2005, Hepatology.
[117] R. Shamloul. Management of honeymoon impotence. , 2006, The journal of sexual medicine.
[118] J. Beavo,et al. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages , 2004, Neurochemistry International.
[119] K. Andersson. Pharmacology of penile erection. , 2001, Pharmacological reviews.
[120] C. S. Patil,et al. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. , 2004, Indian journal of experimental biology.
[121] D. Ingram,et al. Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition , 2005, Psychopharmacology.
[122] I. Izquierdo,et al. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning , 1996, Neuroreport.
[123] H. Ellis. stroke , 1997, The Lancet.
[124] M. Chopp,et al. Activation of the PI3-K/Akt Pathway Mediates cGMP Enhanced-Neurogenesis in the Adult Progenitor Cells Derived from the Subventricular Zone , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[125] A. Blokland,et al. cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. , 2002, European journal of pharmacology.
[126] W. Seeger,et al. Sildenafil treatment for portopulmonary hypertension , 2006, European Respiratory Journal.
[127] T. Münte,et al. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials , 2001, World Journal of Urology.
[128] V. Stecher,et al. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age* , 2006, Current medical research and opinion.